drugset
drugset / Trial / NCT04974359

A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia

NCT04974359 ↗

Phase 1 Terminated 3 enrolled H. Lundbeck A/S
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to find out the effect of Lu AG06466 on the body in participants with fibromyalgia by assessing pain levels, brain signal changes, and psychiatric (mental) assessments.

Timeline

Start
2021-06-24
Primary completion
2022-01-26
Completion
2022-01-26

Outcome

Outcome not reported

Stopped: “Study terminated due to enrolment challenges.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06466 Unknown — Oral

Indications

fibromyalgia